Biotech · Private company
Aravive, Inc.
Track this companyFree. Adds Aravive, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials61 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- BatiraxceptPhase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- PaclitaxelPhase 3 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- AVB-S6-500Phase 2 · IgA NephropathyClinicalTrials.gov · fetched Nov 12, 2026
- batiraxceptPhase 2 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BatiraxceptPhase 2 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Cabozantinib (Cabo)Phase 2 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Nab paclitaxelPhase 2 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Clear Cell Renal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- AVB-S6-500Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Paclitaxel (Pac)Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- Pegylated liposomal doxorubicin (PLD)Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic AdenocarcinomaPHASE1_PHASE2 · TERMINATED · started Jul 28, 2021ClinicalTrials.gov NCT04983407 · fetched Nov 12, 2026
- Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian CancerPHASE3 · TERMINATED · started Apr 22, 2021ClinicalTrials.gov NCT04729608 · fetched Nov 12, 2026
- Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaPHASE1_PHASE2 · TERMINATED · started Feb 26, 2021ClinicalTrials.gov NCT04300140 · fetched Nov 12, 2026
- Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial CarcinomaPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 17, 2020ClinicalTrials.gov NCT04004442 · fetched Nov 12, 2026
- Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA NephropathyPHASE2 · TERMINATED · started Nov 27, 2019ClinicalTrials.gov NCT04042623 · fetched Nov 12, 2026
- Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian CancerPHASE1 · COMPLETED · started Dec 6, 2018ClinicalTrials.gov NCT03639246 · fetched Nov 12, 2026